Expanding portfolio into nanotechnology-based seed treatment solutions
Research & Development
The Client, a major international vegetable breeding company had achieved a leading position in the markets for multiple types of vegetable seeds. However, they were facing growing pressure from increasingly restrictive bans on certain types of chemical seed treatments, as well as their strategic need to improve their organisation’s performance regarding sustainability.
Our client sought to quickly gain a thorough understanding of the relevant aspects of nanotechnology, a complex and unfamiliar technology area, but one which has been growing in importance for applications related to seed treatments. They contacted CamIn for our help in developing the optimal strategy for their entry into this emerging seed treatment technology area.
experts assembled for
the consulting team
weeks project duration
CamIn worked with the client’s R&D leadership team to understand their goals for this expansion of their technology portfolio and to define precisely the scope of our investigation, including the lower and upper size boundaries for the definition of nanoparticles. We then assembled a bespoke team of five technology and industry experts, including those with expertise in novel agrochemical formulations, environmental safety, and agrochemical product development. Crucially, we also sought experts in adjacent industry segments, particularly from the food science and pharmaceuticals sectors, to harvest the benefits of convergence science and to identify out-of-the-box enabling technologies unknown in agriculture.
Our project team performed a thorough, global investigation of all relevant technology sub-areas to identify, characterise, and evaluate nearly 80 individual technologies spanning the full range of technology readiness levels. By systematically analysing and quantitatively benchmarking these technologies, we extracted the most relevant insights and provided our Client with concrete recommendations on the most promising directions for potential investments and R&D work. Our recommendations also discussed potential risks associated with specific technologies, and the reasoning for selecting particular strategic directions.